Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Plasma cell 1

Conditions

Multiple Myeloma 420Lymphoma 53Recurrence 42Neoplasms, Plasma Cell 33Hematologic Neoplasms 33Immunoglobulin Light-chain Amyloidosis 29Smoldering Multiple Myeloma 26Lymphoma, Non-Hodgkin 25Leukemia, Myeloid, Acute 20Leukemia, Lymphocytic, Chronic, B-Cell 20Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Hodgkin Disease 17Myelodysplastic Syndromes 16Monoclonal Gammopathy of Undetermined Significance 13Waldenstrom Macroglobulinemia 11Lymphoma, Mantle-Cell 11Leukemia 11Prostatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Breast Neoplasms 10Paraproteinemias 9Ovarian Neoplasms 9Lung Neoplasms 8Leukemia, Plasma Cell 8Amyloidosis 8Melanoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7

Interventions

pazopanib 1Radiotherapy 1Radiation 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma, Mesenchymal × Plasma cell × 90 days × Clear all
NCT02180867 2026-05-04

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
140 enrolled 22 charts
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Granuloma, Plasma Cell, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Chondrosarcoma, Mesenchymal, Dermatofibrosarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡